Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023)
Source: Science. Unidades: IFSC, FCFRP
Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
ABNT
BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 05 maio 2024.APA
Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201NLM
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 maio 05 ] Available from: https://doi.org/10.1126/science.abo7201Vancouver
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 maio 05 ] Available from: https://doi.org/10.1126/science.abo7201